| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/01/2002 | WO2002058728A2 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses |
| 08/01/2002 | WO2002058723A2 Chemokines as adjuvants of immune response |
| 08/01/2002 | WO2002058709A1 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and uses thereof |
| 08/01/2002 | WO2002058708A1 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| 08/01/2002 | WO2002058701A1 Pharmaceutical dosage forms of epothilones for oral administration |
| 08/01/2002 | WO2002058700A1 Methods of administering epothilone analogs for the treatment of cancer |
| 08/01/2002 | WO2002058699A1 Pharmaceutical forms of epothilones for oral administration |
| 08/01/2002 | WO2002058698A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | WO2002058695A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 08/01/2002 | WO2002058694A2 Method of treating hematologic tumors and cancers using beta lapachone |
| 08/01/2002 | WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 08/01/2002 | WO2002058689A1 Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same |
| 08/01/2002 | WO2002058684A2 Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders |
| 08/01/2002 | WO2002058679A2 Antiangiogenic compounds and an assay for inhibitors of cell invasion |
| 08/01/2002 | WO2002058676A1 Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles |
| 08/01/2002 | WO2002058636A2 Novel cannabimimetic ligands |
| 08/01/2002 | WO2002058626A2 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 08/01/2002 | WO2002058624A2 In situ generation allicin for the treatment of cancer and infectious diseases |
| 08/01/2002 | WO2002058622A2 Sn-38 lipid complexes and methods of use |
| 08/01/2002 | WO2002058546A2 Methods for screening for substances which inhibit fp prostanoid receptor |
| 08/01/2002 | WO2002058450A2 Regulation of cell growth by muc1 |
| 08/01/2002 | WO2002043651A3 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease |
| 08/01/2002 | WO2002042278A3 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 08/01/2002 | WO2002040048A3 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis |
| 08/01/2002 | WO2002036761A9 Compositions and methods for the diagnosis of cancer |
| 08/01/2002 | WO2002030441A3 Treatment of cancers by aplidine in conjunction with a myoprotector |
| 08/01/2002 | WO2002028861A3 Methods and compounds for treating proliferative diseases |
| 08/01/2002 | WO2002026733A3 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES |
| 08/01/2002 | WO2002024226A3 Photosensitisers |
| 08/01/2002 | WO2002022166A3 Tweak receptor agonists as anti-angiogenic agents |
| 08/01/2002 | WO2002020614A3 Endoglin-specific polypeptide, production and use thereof |
| 08/01/2002 | WO2002014319A3 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 08/01/2002 | WO2002012227A3 Indole, azaindole and indazole derivatives having vegf inhibiting activity |
| 08/01/2002 | WO2002010152A3 Novel indole derivatives and their use as medicaments |
| 08/01/2002 | WO2002008285A3 Il-17 molecules and uses thereof |
| 08/01/2002 | WO2002008190A3 Novel heteroaryl derivatives and use thereof as anti-tumour agents |
| 08/01/2002 | WO2002005794A3 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel |
| 08/01/2002 | WO2002004509A3 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 08/01/2002 | WO2002002625A3 Novel fibroblast growth factors and nucleic acids encoding same |
| 08/01/2002 | WO2001096565A3 Binding agents: chimeric ligand/receptor proteins |
| 08/01/2002 | WO2001092551A3 Duplexed parvovirus vectors |
| 08/01/2002 | WO2001090315A3 Production of neurons from stem cells |
| 08/01/2002 | WO2001085213A3 Supports for photosensitizer formulations |
| 08/01/2002 | WO2001083554A3 Anti-inflammatory compounds and uses thereof |
| 08/01/2002 | WO2001082953A3 Methods for treatment of diseases associated with inflammation under non-ischemic conditions |
| 08/01/2002 | WO2001078654A3 Halogentated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 08/01/2002 | WO2001076606A3 Use of uric acid or precursors thereof as a treatment for cancer, aids and the like |
| 08/01/2002 | WO2001075110A3 Mucin-1 specific binding members and methods of use thereof |
| 08/01/2002 | WO2001072836A3 G-protein coupled receptors |
| 08/01/2002 | WO2001070979A9 Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer |
| 08/01/2002 | WO2001070950A3 Antisense nucleic acid molecules targeted to type i collagenase (mmp-1) for inhibition of melanoma invasion |
| 08/01/2002 | WO2001070738A3 Tri-aryl-substituted-ethane pde4 inhibitors |
| 08/01/2002 | WO2001028494A9 Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 08/01/2002 | WO2001026672A9 Induction of a strong immune response to a self-tumor associated antigen |
| 08/01/2002 | WO2001022970A9 Therapy with 2-5a and interferon |
| 08/01/2002 | WO2001012206A3 Soy-glycine extracts and aromatase inhibitors for positively influencing collagen |
| 08/01/2002 | WO2000077040A9 Human intracellular signaling molecules |
| 08/01/2002 | US20020104108 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors |
| 08/01/2002 | US20020103389 Klainetins and their derivatives, method for their preparation and use thereof |
| 08/01/2002 | US20020103380 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction |
| 08/01/2002 | US20020103345 Bispecific immunoglobulin-like antigen binding proteins and method of production |
| 08/01/2002 | US20020103340 Rab proteins |
| 08/01/2002 | US20020103254 Paclitaxel formulation |
| 08/01/2002 | US20020103248 Indole derivatives which are agonists of the progesterone receptor and useful for treatment of carcinoma and adenocarcinomas of uterine leiomyomata, endometriosis or polycystic ovary syndorme in a mammal |
| 08/01/2002 | US20020103247 Indole and dihydroindole derivatives |
| 08/01/2002 | US20020103242 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
| 08/01/2002 | US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same |
| 08/01/2002 | US20020103230 Heterocyclic compounds |
| 08/01/2002 | US20020103229 Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| 08/01/2002 | US20020103227 Nitric oxide synthase inhibitors such as 6(4'-(4-phenethyl-piperazin-1-ylmethyl)-biphenyl-4-yl)-pyridin-2-ylamine for treatment and prevention of central nervous system disorders |
| 08/01/2002 | US20020103214 Novel heteroaryl derivatives and their use as medicaments |
| 08/01/2002 | US20020103211 For treatment of chronic inflammatory disease, chronic intestinalinflammation, arthritis, psoriasis, asthma, autoimmune disorders |
| 08/01/2002 | US20020103207 Tricyclic imine containing compounds having imidazole substituent; antitumor agents |
| 08/01/2002 | US20020103203 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis |
| 08/01/2002 | US20020103195 LPAAT-B inhibitors and uses thereof |
| 08/01/2002 | US20020103191 Antitumor dibenzofluorene derivatives |
| 08/01/2002 | US20020103172 Vitamin d3 derivatives |
| 08/01/2002 | US20020103169 Use of anticancer agents of the phenanthridine class having a specific mechanism of action and cancer therapy |
| 08/01/2002 | US20020103166 2-(4-Chlorophenoxy)-2-oxo-1,3,2-oxazaphosphorinane-3-aceto -hydroxamic acid, for example; antiathritic, -tumor, -metastasis, -proliferative and -ulcer agents; multiple sclerosis; vision defects; skin disorders |
| 08/01/2002 | US20020103141 DNA topoisomerase I and cyclooxygenase-2 (COX-2) inhibiting agents |
| 08/01/2002 | US20020103133 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 08/01/2002 | US20020103130 Amino acid sequence RX1ETX2WX3 (SEQ ID NO: ) wherein X1, X2 and X3 are any amino acid |
| 08/01/2002 | US20020103121 Amino acid sequence of residues 163-199 used to induce apoptosis in a cell |
| 08/01/2002 | US20020102733 Drug delivery system; obtain receptive binding particles, incubate with surface and hydrophilic polymer, incubate with release agent, monitor distribution through biological systems |
| 08/01/2002 | US20020102729 Formulations for electroporation |
| 08/01/2002 | US20020102726 Which forms a reconstructed epidermis, used to test various factors on human skin equivalent, such as drugs, cosmetics, surfactants and detergents |
| 08/01/2002 | US20020102722 Lac shuttle vectors |
| 08/01/2002 | US20020102712 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of viral diseases |
| 08/01/2002 | US20020102711 Polypeptide for use in the treatment of cancer and immunological |
| 08/01/2002 | US20020102707 Nucleotide sequences coding polypeptide for use in the treatment of sexual disorders |
| 08/01/2002 | US20020102685 Novel use of inhibitors of the epidermal growth factor receptor |
| 08/01/2002 | US20020102679 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 08/01/2002 | US20020102676 Nucleotide sequences coding membrane proteins for use in cancer therapy |
| 08/01/2002 | US20020102666 PSCA: prostate stem cell antigen and uses thereof |
| 08/01/2002 | US20020102651 Novel B7-4 molecules and uses therefor |
| 08/01/2002 | US20020102649 Human transport protein homologs |
| 08/01/2002 | US20020102642 Nuclelotide sequences coding preferential protein for use in therapeutic, diagnostic and medical imaging |
| 08/01/2002 | US20020102641 Oncogenic osteomalacia-related gene 1 |
| 08/01/2002 | US20020102640 Nucleotide sequences coding preferential protein for use in the diagnosis, prevention and treatment of cancer |